A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

Also called NCT03941314

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 300 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as a collaborator
Registry
  • NCT NCT03941314
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03941314. Randomized; no masking; primary purpose treatment. Start 2019-06-25 (actual); primary completion 2026-03-19 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease
Condition
Peripheral Arterial Disease
Intervention (Device)
Supera® Peripheral Stent System
Intervention (Device)
EverFlex™ Self-Expanding Peripheral Stent System
Lead sponsor
Kantonsspital Winterthur KSW (class: other)
Collaborator
Abbott (class: industry)
Collaborator
Cantonal Hospital of St. Gallen (class: other)

Record details

Record id
cardio:ct-nct03941314
Content hash
16e6a0642ba8ba9c91088088cf343cc39f3622e6590d61e3528b46f06305cc1b